Laurie Villanueva

Laurie Villanueva has been writing about consumer issues for over two decades, Her work for largely focuses on pharmaceutical and medical device safety, including the ongoing litigation surrounding Risperdal, proton pump inhibitors, Invokana, Levaquin, defective hip implants, the Bair Hugger forced air warming blanket, and IVC filters. Laurie has also devoted a great deal of coverage to women’s health issues, especially recent litigation involving talcum powder, power morcellators, transvaginal mesh, and breast implants.

Laurie graduated from Penn State University in 1990 with a degree in journalism. After spending many years covering local government for various print media outlets, she is now focused on utilizing the internet to raise awareness about important consumer issues.

FDA Announces Campaign to Publicize Allergan Breast Implant Recall

The U.S. Food & Drug Administration (FDA) has announced a new campaign to better publicize a recent recall for certain Allergan textured breast implants due to their association with a rare form of lymphoma. Allergan Aesthetics’ multi-channel campaign will include … Continue reading

Zantac Lawsuits Move Forward, as Federal Litigation Convenes Initial Conference

The federal litigation established earlier this year for Zantac cancer lawsuits finally convened an Initial Conference last month, following a delay necessitated by the global coronavirus pandemic. The conference took place over a period of two days, May 12th and … Continue reading

California Appeals Court Set to Hear Oral Arguments in First Monsanto Roundup Verdict

A California appeals court will hear oral arguments tomorrow in Bayer AG’s bid to dismiss the massive verdict awarded to the plaintiff at the conclusion of the nation’s first Monsanto Roundup trial. About the Monsanto Roundup Appeal The hearing before … Continue reading

FDA Seeks Metformin Recalls after Tests Confirm NDMA Contamination

The U.S. Food & Drug Administration (FDA) has asked five pharmaceutical companies to recall certain extended-release metformin products, after tests confirmed the tablets contained excessive levels of N-Nitrosodimethylamine, a probable human carcinogen. So far, only one – Apotex Pharmaceuticals – … Continue reading

Atrium Hernia Mesh Litigation Grows, as Federal MDL Exceeds 2,100 Filings

Hernia mesh lawsuits involving Atrium Medical Corp.’s C-Qur mesh continue to mount in the federal multidistrict litigation now underway in the U.S. District Court, District of New Hampshire. According the New Hampshire Business Review, 2,136 claims were pending in the … Continue reading

Metformin Lawsuit News: FDA Finds High Levels of Cancer-Causing Chemical in Popular Diabetes Drugs

Mere months after reassuring the public that metformin was safe, the U.S. Food & Drug Administration (FDA) has acknowledged that a new round of tests detected excessive levels of a potentially cancer-causing chemical in some extended release versions of the … Continue reading

Ethicon Physiomesh News: Federal Court Reschedules Hernia Mesh Lawsuit Trials

Thousands of hernia mesh lawsuits involving Ethicon, Inc.’s Physiomesh Composite Flexible mesh continue to move forward in the U.S. District Court, Northern District of Georgia, where the first bellwether trial is now scheduled to get underway this coming November. Ethicon … Continue reading

Zantac Lawsuit Court Sets Deadlines for Initial Census

The Zantac litigation currently underway in the U.S. District Court, Southern District of Florida, continues to move forward, following the issuance of an order establishing  deadlines for the proceeding’s Initial Census. Zantac Lawsuits Undergoing 2-Phase Initial Census There are currently … Continue reading

South Korea Bans Some Metformin Products Over NDMA Contamination

Drug regulators in South Korea have suspended sales of nearly three dozen metformin products contaminated with N-Nitrosodimethylamine (NDMA), a probable human carcinogen. According to the Yonhap News Agency, South Korea’s Ministry of Food and Drug Safety, 31 of 254 metformin products … Continue reading

Elmiron Class Action Lawsuit Seeks Medical Monitoring for Retinal Damage

The manufacturers of Elmiron (pentosan polysulfate sodium) are facing yet another lawsuit, this time a class action complaint that seeks medical monitoring on behalf of consumers allegedly at risk for retinal damage and vision loss. Elmiron and Retinal Damage Elmiron … Continue reading

Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest